Thu.Jun 15, 2023

article thumbnail

Opinion: What happens when patients beat their doctors to their test results

STAT

Not so long ago, a father broke down in tears with me over Zoom — tears of relief. When this father had received test results for his child, some of the values in the report appeared in red. That font color made him terrified for his child’s health. It was only when we hopped on Zoom to go over the results that I was able to reassure him: They were in red because the system was comparing them with adult range values.

251
251
article thumbnail

Boosting the cell and gene therapy workforce with a skilled, localized approach

PharmaVoice

Experts provide a roadmap for how the industry can work with academia to ensure a robust talent pipeline for the burgeoning field.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mandy Cohen, seen as next CDC director, would bring political chops to an agency lacking them

STAT

The Centers for Disease Control and Prevention may be about to undergo a paradigm shift with the anticipated appointment of former North Carolina health secretary Mandy Cohen as the agency’s next director. The Atlanta-based CDC has always prided itself at being at a remove from Washington, and the politics that engulf it. With 634 miles separating the U.S.

241
241
article thumbnail

Verve partners with Lilly on gene editing therapy for heart disease

BioPharma Dive

Lilly will pay the genetic medicine specialist $60 million upfront to work together on a treatment targeting a risk factor known as Lp(a).

124
124
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

White House ‘naloxone summit’ omitting prominent advocates for lower costs

STAT

The invite list for the White House’s upcoming “summit” on naloxone pricing and accessibility has some noteworthy omissions. Two of the most prominent organizations focused on providing cheaper overdose-reversal medications will be conspicuously absent from Tuesday’s event : Harm Reduction Therapeutics, a nonprofit drug manufacturer currently seeking approval for a naloxone nasal spray, and Remedy Alliance, a group that distributes cheap naloxone to harm-reduction gro

240
240
article thumbnail

Health secretary commits to tech, genomics and prevention agenda

The Pharmacist

Health secretary Steve Barclay outlined his commitment to investing in technology, preventing ill health, and supporting innovation such as personalised medicines in a speech at the NHS Confed Expo today. This comes as the NHS mandate, which sets out the government’s asks of the NHS, was published today. It outlined three key priorities: cutting waiting […] The post Health secretary commits to tech, genomics and prevention agenda appeared first on The Pharmacist.

98

More Trending

article thumbnail

Guest Blog: Understanding Myasthenia Gravis, a Rare Neuromuscular Disease

Putting Patients First Blog

Guest Blog: Understanding Myasthenia Gravis, a Rare Neuromuscular Disease June 15, 2023 By Samantha Masterson, President and CEO, Myasthenia Gravis Foundation of America When graduate student Audrey Getman first experienced myasthenia gravis symptoms, she thought she was having a stroke. “It came on gradually – I started noticing some facial weakness and then I couldn’t use my mouth,” she says.

article thumbnail

FDA advisers endorse updating Covid vaccines to target latest Omicron strain

STAT

The Covid-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by mutated versions as the virus rapidly evolves.

Vaccines 234
article thumbnail

Eloxx repackages ELX-02 data in cystic fibrosis as it eyes pivotal trial

Pharmaceutical Technology

Eloxx has revealed its lead candidate ELX-02 improved predicted forced expiratory volume (ppFEV1) in patients with Class 1 cystic fibrosis (CF) in a new analysis of a Phase II trial that missed its efficacy endpoints. Following underwhelming topline results from the Phase II trial (NCT04135495) announced in late 2022, Eloxx recalculated the results using the change in ppFEV1 (a secondary outcome) from day 1 instead of from baseline.

98
article thumbnail

STAT+: Instead of credible data, PDS Biotech delivers ‘results might get better, later’ promises

STAT

Tumor response rate is a common way to assess the efficacy of a cancer drug. It’s not a perfect measure, for sure, but it’s easy to calculate and understand — or it should be. PDS Biotech is a small developer of cancer drugs that is zealously seeking investor eyeballs, yet it can’t seem to grasp the tumor-response concept.

Immunity 221
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pharmacies could have played key role in anti-vaping, shadow health secretary suggests

The Pharmacist

Managing the sale of e-cigarettes through community pharmacies could have prevented soaring levels of vaping among children, shadow health secretary Wes Streeting has suggested. In response to an audience question at NHS Confed Expo yesterday afternoon, Mr Streeting said that there a role for community pharmacies to play a bigger part in preventing ill health […] The post Pharmacies could have played key role in anti-vaping, shadow health secretary suggests appeared first on The Pharmacist

article thumbnail

Suicides and homicides among young Americans jumped early in the pandemic, study says

STAT

The homicide rate for older U.S. teenagers rose to its highest point in nearly 25 years during the COVID-19 pandemic, and the suicide rate for adults in their early 20s was the worst in more than 50 years, government researchers said Thursday. The Centers for Disease Control and Prevention report examined the homicide and suicide rates among 10- to 24-year-olds from 2001 to 2021.

219
219
article thumbnail

Lack of pharmacy representation on ICBs 'staggering', says committee chair

The Pharmacist

Representation of community pharmacy within integrated care boards (ICBs) is critical to the success of the government’s primary care recovery plan, chair of Health and Social Care Committee (HSCC) Steve Brine suggested today. Meanwhile leaders from NHS England and integrated care systems (ICSs) have highlighted the need to implement preventative healthcare, such as vaccination, amid […] The post Lack of pharmacy representation on ICBs 'staggering', says committee chair appeared

article thumbnail

Opinion: STAT+: How I’m helping companies think through whether they should cover GLP-1s like Ozempic for employees

STAT

We have a knack in the U.S. for blurring behavior and medicine. Look at weight. For a long time, we’ve treated obesity as a moral failing, a lack of willpower. That was wrong. Now we’re treating weight as a medical issue that can be cured by pill or injection. Is this any better? Up to 130 million Americans could qualify for Ozempic or other GLP-1s (glucagon-like peptides), which cost nearly $1,000 per month.

216
216
article thumbnail

Choosing a Specialty Pharmacy to Support Patients with Recurrent Pericarditis

Orsini Pharmacy

Recurrent Pericarditis (RP) is a painful auto-inflammatory cardiovascular disease that occurs when patients with acute pericarditis experience one or more pericarditis episodes after being symptom-free for 4-6 weeks. The symptoms associated with RP affect patients' quality of life, can limit physical activities, and lead to frequent emergency department visits and hospitalizations.

article thumbnail

STAT+: USDA to push food producers to substantiate claims that animals are raised without antibiotics

STAT

The U.S. Department of Agriculture is launching a program to ensure food producers substantiate claims that their animals are not raised on antibiotics, a move that reflects ongoing concerns that unnecessary use of these medicines causes resistance among humans. The agency will conduct a sampling project to assess antibiotic residues in cattle destined for the so-called raised without antibiotics market.

article thumbnail

Free prescriptions for over-60s to stay

The Pharmacist

The government has committed to keeping prescriptions free for over-60s, it has been announced. This follows a consultation on whether the age limit for free prescriptions should be brought in line with the state pension age – meaning that people would not have been able to get a free prescription until the age of 66, […] The post Free prescriptions for over-60s to stay appeared first on The Pharmacist.

74
article thumbnail

Listen: Biogen’s messy board, Laronde’s data problem, & the downside of a boom

STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data.

188
188
article thumbnail

Sourav Ganguly and Anil Kumble partners with Mankind Pharma

Express Pharma

The company has launched a comprehensive 360-degree marketing campaign Mankind Pharma has launched a new range of medicines which will boast the same level of Active Pharmaceutical Ingredient (API) quality in the Drug Master File (DMF) of the API’s submitted to FDA. To promote and generate awareness about these medicines, the pharma giant has partnered with cricket legends Sourav Ganguly and Anil Kumble & launched a comprehensive 360-degree marketing campaign.

93
article thumbnail

STAT+: Pharmalittle: PBMs are targeted in yet another congressional bill; access to new Alzheimer’s drug may not happen quickly

STAT

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear and sunny skies — and delicious breezes — enveloping the Pharmalot campus this morning. This calls for celebration with a cup of stimulation, and we are opening a new package of salted caramel mocha for the occasion.

article thumbnail

Pfizer migraine medicine, Nurdec, put on the map by Lady Gaga

Outsourcing Pharma

Coordinating with Migraine and Headache Awareness Month (MHAM), this June, Pfizer has announced it is partnering with multi-award winning, singer and actress, Lady Gaga, who was diagnosed with migraine when she was 14.

88
article thumbnail

Birmingham University reveals antimicrobial discovery

Pharma Times

Researchers show silver retains antimicrobial activity for longer when it is infused into bioactive glass - News - PharmaTimes

102
102
article thumbnail

ASCO 2023: Protecting our progress in the fight against cancer

PhRMA

I always look forward to the American Society of Clinical Oncology’s Annual Meeting, which took place in Chicago earlier this month. It’s an opportunity for the world’s leading cancer experts to celebrate the latest innovations that are changing the treatment paradigm for patients with this disease.

89
article thumbnail

Quality Ratings: Importance of Reducing Readmissions in Hospitals

cureatr

When it comes time for a patient to choose their healthcare provider, it's important for them to understand who they're choosing to help ensure they are getting the best care possible. One sure way for the patient to know what to expect from their provider is by reviewing rankings and ratings around quality measures before deciding.

article thumbnail

Development of universal influenza vaccines gaining precedence: GlobalData

Express Pharma

The current influenza vaccines only provide protection against a limited number of strains Interim results from a recent study on influenza vaccine effectiveness (VE) estimations for the 2022/2023 season across six European countries has found VE to be only 27-44 per cent for influenza A and ≥ 50 per cent for influenza B, highlighting a longstanding unmet need for more effective seasonal influenza vaccines.

article thumbnail

Why is microbiological testing in medical device manufacturing important?

European Pharmaceutical Review

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. Microbiological testing is essential for quality control , regulatory compliance and can help minimise the risk of microbial contamination. This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures.

article thumbnail

Glance in the future: Explore innovative solutions at PHARMAP 2023

Express Pharma

PHARMAP 2023 gathered pharma companies, CMOs and CDMOs, governmental bodies to exchange experience in digital transformation and discuss innovative solutions and business practices Presenting innovative solutions and contributing to further development of ongoing pharmaceutical trends were the main directions of Pharmaceutical Manufacturing and Packaging Congress.

article thumbnail

Reject efforts to undermine America’s R&D ecosystem

PhRMA

America’s biopharmaceutical research companies are central to the research and development (R&D) of innovative medicines in the United States. Unfortunately, a new report by Sen. Sanders mischaracterizes the role the National Institutes of Health plays in the research and development (R&D) process and risks stifling the innovative biopharmaceutical ecosystem vital to advancing medicines for patients.

80
article thumbnail

Positive profile for Enterome's lymphoma candidate

Pharma Times

EO2463 is an experimental treatment for indolent non-Hodgkin B cell lymphoma - News - PharmaTimes

104
104
article thumbnail

Glenmark reduces cost of Trastuzumab treatment in India

Express Pharma

A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country Glenmark Pharmaceuticals has announced a price reduction of Trastuzumab for HER2-positive breast cancer, being marketed in India under the brand name ‘ Trumab’. A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country.

82
article thumbnail

Genetic testing update with 23andMe’s Noura Abul-Husn

pharmaphorum

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe.

82
article thumbnail

Gedeon Richter buys Consilient Health’s contraceptive range for £32.5M

Outsourcing Pharma

Multinational pharmaceutical company, Gedeon Richter UK Ltd, announced this week that it has acquired full marketing and distribution rights to a contraceptive range.

article thumbnail

AbbVie, Coherus mend dispute over low-price Humira biosimilar

BioPharma Dive

The biosimilar developer’s plans to set steep discounts on its copycat version of AbbVie’s Humira set off a legal back-and-forth between the companies.

article thumbnail

Astellas extends protein degrader drive with Cullgen deal

pharmaphorum

Astellas extends protein degrader drive with Cullgen deal Phil.

92
article thumbnail

Pharmaceutical companies search for IRA response as they brace for drug pricing talks

BioPharma Dive

Lobbying group PhRMA does not expect any near-term changes to the IRA’s drug pricing provisions, but is attempting to lay groundwork for future changes.